Liminal BioSciences Inc. LMNL
8.50 +8.50
Day range unavailable
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 7.53
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current year | -8.37 | -8.37 – -8.37 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | -9.11 | -9.11 – -9.11 | -8.37 | -8.8% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 24, 2021 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Jun 2, 2021 | Piper Sandler | Downgrade | Overweight | Neutral |
| Feb 18, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 21, 2020 | Piper Sandler | Initiated | — | Overweight |